As of 2026-08-11, the Intrinsic Value of Cogent Biosciences Inc (COGT) is -10.37 USD. This COGT valuation is based on the model Peter Lynch Fair Value. With the current market price of 41.53 USD, the upside of Cogent Biosciences Inc is -124.96%.
Based on its market price of 41.53 USD and our intrinsic valuation, Cogent Biosciences Inc (COGT) is overvalued by 124.96%.
Note: result may not be accurate due to the invalid valuation result of Peter Lynch's fair value model.
| Range | Selected | Upside | |
| a | |||
| Fair Value | -10.37 - -10.37 | -10.37 | -124.96% |
| P/E | (58.97) - (57.85) | (58.16) | -240.0% |
| DDM - Stable | (31.71) - (247.89) | (139.80) | -436.6% |
| DDM - Multi | (10.85) - (65.88) | (18.63) | -144.9% |
| Market Cap (mil) | 7,096.23 |
| Beta | -0.02 |
| Outstanding shares (mil) | 170.87 |
| Enterprise Value (mil) | 7,078.20 |
| Market risk premium | 4.60% |
| Cost of Equity | 6.67% |
| Cost of Debt | 5.00% |
| WACC | 6.58% |